We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals
AGIO

161 hedge funds and large institutions have $1.63B invested in Agios Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 49 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

198% more call options, than puts

Call options by funds: $39M | Put options by funds: $13.1M

92.87% more ownership

Funds ownership: 0% → 92.87% (+93%)

29% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 49

4% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 24

1% less funds holding

Funds holding: 163 → 161 (-2)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

18% less capital invested

Capital invested by funds: $1.99B → $1.63B (-$364M)

Holders
161
Holders Change
-2
Holders Change %
-1.23%
% of All Funds
4.03%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.15%
New
23
Increased
63
Reduced
49
Closed
24
Calls
$39M
Puts
$13.1M
Net Calls
+$25.9M
Net Calls Change
-$3M

Top Buyers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
+$67.8M
2
AG
Artal Group
Luxembourg
+$18.4M
3
CGT
Capital Guardian Trust
California
+$9.24M
4
BIT
BlackRock Institutional Trust
California
+$9.06M
5
BB
BB Biotech
Switzerland
+$8.4M

Top Sellers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$18.2M
2
Citadel Advisors
Citadel Advisors
Florida
-$13.7M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$12.4M
4
BA
BlackRock Advisors
Delaware
-$9.61M
5
EC
EcoR1 Capital
California
-$9.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
151
US Bancorp
Minnesota
$5K – – –
Bessemer Group
152
Bessemer Group
New Jersey
$4K – – –
SBL
153
Sargent Bickham Lagudis
Colorado
$3K – – –
FHA
154
First Horizon Advisors
Tennessee
$2K – – –
SEI Investments
155
SEI Investments
Pennsylvania
$1K -$892 -17 -37%
MFS
156
MSI Financial Services
Massachusetts
$1K – – –
TFO
157
Tarbox Family Office
California
$1K – – –
Envestnet Asset Management
158
Envestnet Asset Management
Illinois
$1K +$1.1K +21 New
ACA
159
Avoro Capital Advisors
New York
– -$7.92M -150,000 Closed
Capital Fund Management (CFM)
160
Capital Fund Management (CFM)
France
– -$5.04M -95,510 Closed
Jacobs Levy Equity Management
161
Jacobs Levy Equity Management
New Jersey
– -$4.15M -78,537 Closed
Artisan Partners
162
Artisan Partners
Wisconsin
– -$3.2M -60,561 Closed
QIM
163
Quantitative Investment Management
Virginia
– -$2.18M -41,300 Closed
AP
164
AlpInvest Partners
Netherlands
– -$1.58M -30,000 Closed
ACP
165
Acuta Capital Partners
California
– -$1.32M -25,000 Closed
Jane Street
166
Jane Street
New York
– -$1.02M -19,327 Closed
HLA
167
Hamilton Lane Advisors
Pennsylvania
– -$1.02M -19,280 Closed
EEG
168
E.E. Geduld
– -$792K -15,000 Closed
CC
169
Cannell & Co
New York
– -$776K -14,700 Closed
CCM
170
Cadence Capital Management
Massachusetts
– -$702K -13,290 Closed
SSA
171
Schonfeld Strategic Advisors
New York
– -$581K -11,000 Closed
PAM
172
Panagora Asset Management
Massachusetts
– -$555K -10,510 Closed
D.E. Shaw & Co
173
D.E. Shaw & Co
New York
– -$481K -9,100 Closed
GC
174
Globeflex Capital
California
– -$454K -8,600 Closed
OAC
175
OMERS Administration Corp
Ontario, Canada
– -$285K -5,400 Closed
4 5 6
7
8

AGIO Hedge Fund Activity: Q4 2016 in Review

161 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q4 2016, worth a combined $1.63B — down 18% from $1.99B a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of AGIO and 23 opened new positions — a net loss of 1 holder — while 49 trimmed existing stakes and 63 added.

The largest buyer was Capital International Investors, adding an estimated $67.8M. The largest seller was Lord, Abbett & Co, cutting an estimated $18.2M.

  • 161 institutional investors held Agios Pharmaceuticals (AGIO) as of Q4 2016, down from 163 in Q3 2016.
  • Funds reported $1.63B of Agios Pharmaceuticals stock for Q4 2016, down 18% quarter-over-quarter.
  • 23 funds opened new Agios Pharmaceuticals positions in Q4 2016 and 24 closed out, a net change of -1 holder.
  • The largest Agios Pharmaceuticals buyer in Q4 2016 was Capital International Investors, an estimated $67.8M added.
  • The largest Agios Pharmaceuticals seller in Q4 2016 was Lord, Abbett & Co, an estimated $18.2M sold.

Based on aggregated 13F filings for Q4 2016.